Literature DB >> 33486984

Renal Natriuretic Peptide Receptor-C Deficiency Attenuates NaCl Cotransporter Activity in Angiotensin II-Induced Hypertension.

Shuai Shao1, Xiao-Dong Li1, Yuan-Yuan Lu1, Shi-Jin Li1, Xiao-Hui Chen1, Han-Dan Zhou1, Shun He1, Yue-Tong Guo1, Xiao Lu1, Ping-Jin Gao1, Ji-Guang Wang1.   

Abstract

Genome-wide association studies have identified that NPR-C (natriuretic peptide receptor-C) variants are associated with elevation of blood pressure. However, the mechanism underlying the relationship between NPR-C and blood pressure regulation remains elusive. Here, we investigate whether NPR-C regulates Ang II (angiotensin II)-induced hypertension through sodium transporters activity. Wild-type mice responded to continuous Ang II infusion with an increased renal NPR-C expression. Global NPR-C deficiency attenuated Ang II-induced increased blood pressure both in male and female mice associated with more diuretic and natriuretic responses to a saline challenge. Interestingly, Ang II increased both total and phosphorylation of NCC (NaCl cotransporter) abundance involving in activation of WNK4 (with-no-lysine kinase 4)/SPAK (Ste20-related proline/alanine-rich kinase) which was blunted by NPR-C deletion. NCC inhibitor, hydrochlorothiazide, failed to induce natriuresis in NPR-C knockout mice. Moreover, low-salt and high-salt diets-induced changes of total and phosphorylation of NCC expression were normalized by NPR-C deletion. Importantly, tubule-specific deletion of NPR-C also attenuated Ang II-induced elevated blood pressure, total and phosphorylation of NCC expression. Mechanistically, in distal convoluted tubule cells, Ang II dose and time-dependently upregulated WNK4/SPAK/NCC kinase pathway and NPR-C/Gi/PLC/PKC signaling pathway mediated NCC activation. These results demonstrate that NPR-C signaling regulates NCC function contributing to sodium retention-mediated elevated blood pressure, which suggests that NPR-C is a promising candidate for the treatment of sodium retention-related hypertension.

Entities:  

Keywords:  blood pressure; cardiovascular disease; diuretics; hydrochlorothiazide; phosphorylation

Year:  2021        PMID: 33486984     DOI: 10.1161/HYPERTENSIONAHA.120.15636

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  3 in total

1.  Neohesperidin Protects Angiotensin II-Induced Hypertension and Vascular Remodeling.

Authors:  Jingsi Zhang; Yuanshu Hui; Fengyi Liu; Qian Yang; Yi Lu; Yeting Chang; Qinlong Liu; Yanchun Ding
Journal:  Front Pharmacol       Date:  2022-05-23       Impact factor: 5.988

2.  Broadening the Spectrum of Loss-of-Function Variants in NPR-C-Related Extreme Tall Stature.

Authors:  Peter Lauffer; Eveline Boudin; Daniëlle C M van der Kaay; Saskia Koene; Arie van Haeringen; Vera van Tellingen; Wim Van Hul; Timothy C R Prickett; Geert Mortier; Eric A Espiner; Hermine A van Duyvenvoorde
Journal:  J Endocr Soc       Date:  2022-02-10

Review 3.  Genetic Modifications to Alter Blood Pressure Level.

Authors:  Hiroki Ohara; Toru Nabika
Journal:  Biomedicines       Date:  2022-08-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.